The localisation characteristics of PAI2 allow 213Bi to deliver a large fraction of the total energy to the nucleus of the most malignant prostate cancer cells while irradiation of normal tissue around the target cell is greatly reduced or absent. The gene discussed is SERPINB2; the disease is prostate carcinoma.